Hopman Mark Insider Trades & Stock Holdings

Chief Commercial Officer · Beta Bionics, Inc. · Latest filing Oct 1, 2026

Hopman Mark, Chief Commercial Officer at Beta Bionics, Inc. has 1 Form 4 trade on file since Oct 1, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($7.02K), net -$7.02K. Latest filing: disposed of 370 shares of $BBNX on Oct 1, 2026 at $18.96.

Trades on file

1

Open-market bought

$0

Open-market sold

$7.02K

Net open-market

-$7.02K

Latest filing

Oct 1, 2026

All insider trades by Hopman Mark

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 1, 2026	$BBNX	Sell (Open-market sale) 10b5-1	370	$18.96	$7.02K			-7.6%			Chief Commercial Officer		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Hopman Mark traded

• $BBNX

Frequently asked questions

Has Hopman Mark been buying or selling stock?

Hopman Mark has 0 open-market purchases and 1 open-market sale on file, net -$7.02K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Hopman Mark's latest insider trade?

disposed of 370 shares of $BBNX on Oct 1, 2026 at $18.96.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.